Repaglinide
Repaglinide is an insulin secretagogue for the treatment of type-2 diabetes mellitus[1].
Product Specifications
CAS Number
[135062-02-1]
Product Name Alternative
AG-EE 623ZW
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Potassium Channel
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease; Cancer
Assay Protocol
https://www.medchemexpress.com/Repaglinide.html
Concentration
10mM
Purity
99.89
Solubility
DMSO : ≥ 50 mg/mL
Smiles
CC(C)C[C@H](NC(CC1=CC(OCC)=C(C(O)=O)C=C1)=O)C2=CC=CC=C2N3CCCCC3
Molecular Formula
C27H36N2O4
Molecular Weight
452.59
Precautions
H302, H315, H319, H335
References & Citations
[1]Wang LC, et al. Characteristics of repaglinide and its mechanism of action on insulin secretion in patients with newly diagnosed type-2 diabetes mellitus.Medicine (Baltimore) . 2018 Sep;97 (38) :e12476.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
